Clinical Trial Update: Study to Assess the Seroprevalence of Anti-Tat Antibodies in HIV-infected Patients

View source ↗

Summary

This completed clinical trial evaluated how common antibodies against the HIV Tat protein are among people with HIV.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Snippet

Sponsor: Barbara Ensoli, MD | Conditions: HIV Infection | Status: COMPLETED